AIM:To analyze the outcome of clinical pathways for patients with primary acute angle-closure glaucoma in our hospital for two years and evaluate the value of this way. METHODS:Eighty-three eyes of 82 patients who suffered primary acute angle-closure glaucoma from January 2010 to December 2011 were cured with filtering operation (trabeculectomy or composite trabeculectomy) by managing with clinical path, they are divided path group. The control group was another 67 patients from January 2008 to December 2009, who suffered the same disease and cured with the same operation not by managing with clinical path. The working days before surgery, days in hospital, cost for cure, curative effect, and degree of satisfaction of patients were all recorded for analysis. RESULTS:The path group had an average of 2.6 working days before surgery, 7.0 days in hospital, cost of 2158 yuan for cure, degree of satisfaction of patients(974%). The control group had an average of 4.2 working days before surgery, 11.2 days in hospital, cost of 2630 yuan for cure, degree of satisfaction of patients(90.2%). They were all statistically different(P＜0.05), but there was no difference in curative effect(P>0.05). CONCLUSION: The clinical path for patients with primary acute angle-closure glaucoma can not only shorten working days before surgery and days in hospital, but also save cost for cure and improve the degree of satisfaction of patients.